His name splits the Indian drug industry down the middle. Dinesh Thakur is either admired for his tireless zeal to bring about reform in India’s drug-regulatory system, or tempers flare up at the mention of his name. His motives are often questioned for chasing an “agenda” to malign drugmakers of India, which prides itself on being the pharmacy of the world. But a closer look reveals the merit in his assertions. Thakur has studied India’s
Synopsis At a conference last year, India’s new drug controller general Rajeev Raghuvanshi, who was then the scientific director at the Indian Pharmacopeia Commission, cited examples of drugs found to be less effective than desired. Having worked in the industry, he knows its shortcomings. But amid pressure from lobbyists and state agencies that follow different […]
Synopsis A recent study found that 101 million Indians are living with diabetes. From 70 million just four years ago, that’s a jump of over 40%. What’s worse, another 136 million are on the brink of getting the disease. The economic impact of managing a chronically sick population can seriously hobble India’s demographic edge as […]
Bhikaji Nirgun (on wheelchair), who underwent a heart transplant with Pravin Kulkarni (extreme left), the lead heart transplant surgeon at Jupiter Hospital, Thane. Synopsis The success of a heart transplant hinges on several factors working in sync. While the deft hands of the surgeons racing against time and state-of-the-art facilities are pre-requisites, many other critical […]